Losartan and K-tab drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Losartan (losartan potassium) and K-tab (potassium chloride). Common drug interactions include hair colour changes among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Losartan and K-tab. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.
What is Losartan?
Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,686 Losartan users. Check the latest studies of Losartan.
What is K-tab?
K-tab has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 974 K-tab users. Check the latest studies of K-tab.
68 people who take Losartan and K-tab together, and have interactions are studied.

What are the common drug interactions of Losartan and K-Tab, by gender? *:
female:
- Hair colour changes
- Hair disorder
- Abdominal discomfort
- Abdominal distension
- Abdominal hernia
- Abdominal pain upper
- Abscess limb (limb infection)
- Acute respiratory distress syndrome
- Anaemia (lack of blood)
- Anxiety
male:
- Drug ineffective
- Hospitalisation
- Anaemia (lack of blood)
- Angiopathy (generic term for a disease of the blood vessels)
- Anti-erythropoietin antibody positive
- Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
- Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Axillary mass
- Back pain
What are the common drug interactions of Losartan and K-Tab, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Hospitalisation
20-29:
n/a
30-39:
- Anaemia (lack of blood)
- Anti-erythropoietin antibody positive
- Aplasia pure red cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells)
- Asthenia (weakness)
- Drug ineffective
40-49:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Pneumonia
50-59:
- Stress
- Pneumonia
- Pulmonary embolism (blockage of the main artery of the lung)
- Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
- Cytomegalovirus myocarditis (heart muscle infection with cytomegalo virus)
- Decreased appetite
- Hair colour changes
- Hair disorder
- Pruritus (severe itching of the skin)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
60+:
- Diarrhoea
- Back pain
- Alopecia (absence of hair from areas of the body)
- Cardiac failure congestive
- Cough
- Disease progression
- Drug hypersensitivity
- Heart rate increased
- Nausea (feeling of having an urge to vomit)
- Pain
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 14.71%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 11.76%
- Pain: 8 people, 11.76%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 10.29%
- Stress And Anxiety: 6 people, 8.82%
- Depression: 6 people, 8.82%
- Wheezing (a high-pitched whistling sound made while you breath): 5 people, 7.35%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 7.35%
- Breast Cancer Female: 5 people, 7.35%
- Neuralgia (pain in one or more nerves): 4 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Losartan and K-tab?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Losartan and K-tab:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Losartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of K-tab:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Losartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between K-tab and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on losartan potassium and potassium chloride (the active ingredients of Losartan and K-tab, respectively), and Losartan and K-tab (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Repaglinide and Olmetec - now
- Could Lisdexamfetamine Dimesylate cause Dystonia Aggravated? - a second ago
- Drug interactions of Spravato and Hydroxyzine Hydrochloride - 13 seconds ago
- Zebeta vs. Labetalol Hydrocloride, side effect and effectiveness comparison - 18 seconds ago
- Could Humalog cause Heart Valve Incompetence? - 25 seconds ago
- Could Tylenol cause Pigmentation Disorder? - 26 seconds ago
- Lotensin vs. Tiamate, side effect and effectiveness comparison - 37 seconds ago
- Drug interactions of Locholest and Rebetol - 43 seconds ago
- Could Effexor Xr cause Gingival Ulceration? - 43 seconds ago
- Could Effexor Xr cause Dysstasia? - 45 seconds ago